Integrin α IIIa Antibodies

Santa Cruz Biotechnology delivers a wide array of Integrin α IIIa monoclonal antibodies for research in cell adhesion, migration, and signaling pathways. Integrin α IIIa monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Integrin α IIIa, also known as CD61, plays a crucial role in mediating cell-extracellular matrix interactions and is essential for platelet aggregation and wound healing. Its involvement in various cellular processes makes Integrin α IIIa a significant target in cancer research and therapeutic development. Understanding the function of Integrin α IIIa can provide insights into tumor progression and metastasis. Integrin α IIIa monoclonal antibodies enable researchers to investigate cellular mechanisms involved in platelet function and vascular development. Advanced research techniques utilizing Integrin α IIIa monoclonal antibodies have revealed new pathways in cancer biology and potential therapeutic targets. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies for Integrin α IIIa continue to advance scientific understanding of cellular adhesion and migration in health and disease.